Edition:
United States

Supernus Pharmaceuticals Inc (SUPN.OQ)

SUPN.OQ on NASDAQ Stock Exchange Global Market

38.05USD
3:59pm EST
Change (% chg)

$0.89 (+2.40%)
Prev Close
$37.16
Open
$37.17
Day's High
$38.06
Day's Low
$36.46
Volume
157,839
Avg. Vol
211,130
52-wk High
$61.25
52-wk Low
$30.16

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.49 December 18 Jan 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 5 5 5 4
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.70 1.70 1.70 1.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 2 108.25 110.60 105.90 --
Quarter Ending Jun-19 2 118.35 121.10 115.60 --
Year Ending Dec-19 10 460.44 483.00 437.30 485.19
Earnings (per share)
Quarter Ending Mar-19 2 0.49 0.53 0.44 --
Quarter Ending Jun-19 2 0.57 0.60 0.55 --
Year Ending Dec-19 10 2.36 2.65 2.07 2.19
LT Growth Rate (%) 1 37.00 37.00 37.00 22.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 100.61 103.00 2.38 2.37
Quarter Ending Jun-18 99.42 99.54 0.12 0.12
Quarter Ending Mar-18 85.02 90.43 5.41 6.36
Quarter Ending Dec-17 87.10 88.43 1.33 1.53
Quarter Ending Sep-17 79.16 80.40 1.24 1.57
Earnings (per share)
Quarter Ending Sep-18 0.41 0.52 0.11 27.45
Quarter Ending Jun-18 0.43 0.57 0.14 32.56
Quarter Ending Mar-18 0.33 0.49 0.16 50.17
Quarter Ending Dec-17 0.27 0.44 0.17 62.96
Quarter Ending Sep-17 0.27 0.29 0.02 6.42

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 108.25 108.25 108.05 108.05 --
Quarter Ending Jun-19 118.35 118.35 119.10 119.10 --
Year Ending Dec-19 460.44 464.74 475.65 478.29 485.19
Earnings (per share)
Quarter Ending Mar-19 0.49 0.49 0.52 0.52 --
Quarter Ending Jun-19 0.57 0.57 0.62 0.62 --
Year Ending Dec-19 2.36 2.40 2.44 2.47 2.19

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 0 0 1 0
Quarter Ending Jun-19 0 0 0 1
Year Ending Dec-19 0 1 2 8
Earnings
Quarter Ending Mar-19 0 0 0 1
Quarter Ending Jun-19 0 0 0 1
Year Ending Dec-19 0 1 2 6